Skip header and navigation

6 records – page 1 of 1.

Clinical care to incorporate evidence-based technological advances

https://policybase.cma.ca/en/permalink/policy399
Date
2000-Aug-16
Topics
Health systems, system funding and performance
Health information and e-health
Resolution
GC00-196
That federal, provincial and territorial governments respond to the health care needs of Canadians by ensuring the provision of clinical care that continually incorporates evidence-based technological advances in information, prevention, and diagnostic and therapeutic services.
Policy Type
Policy resolution
Last Reviewed
2014-Mar-01
Date
2000-Aug-16
Topics
Health systems, system funding and performance
Health information and e-health
Resolution
GC00-196
That federal, provincial and territorial governments respond to the health care needs of Canadians by ensuring the provision of clinical care that continually incorporates evidence-based technological advances in information, prevention, and diagnostic and therapeutic services.
Less detail

Government funding for health information technology

https://policybase.cma.ca/en/permalink/policy402
Date
2000-Aug-16
Topics
Health information and e-health
Resolution
GC00-200
That the federal, provincial and territorial governments fund the health information technology required to enhance the delivery of quality care and sustain the health care system.
Policy Type
Policy resolution
Last Reviewed
2014-Mar-01
Date
2000-Aug-16
Topics
Health information and e-health
Resolution
GC00-200
That the federal, provincial and territorial governments fund the health information technology required to enhance the delivery of quality care and sustain the health care system.
Less detail

Essential drugs for the exclusive use of developing countries

https://policybase.cma.ca/en/permalink/policy415
Date
2000-Aug-16
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC00-221
The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
Policy Type
Policy resolution
Last Reviewed
2014-Mar-01
Date
2000-Aug-16
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
Resolution
GC00-221
The CMA calls on governments and pharmaceutical manufacturers in Canada to ensure a supply of essential drugs for the exclusive use of developing countries, and to offset the numerous barriers hindering access to these drugs.
Less detail

Professional development as part of CMA e-strategy

https://policybase.cma.ca/en/permalink/policy468
Date
2000-Aug-16
Topics
Health human resources
Health information and e-health
Resolution
GC00-12
That General Council endorse Canadian Medical Association's offering of professional development to physicians as part of the Canadian Medical Association's e-strategy.
Policy Type
Policy resolution
Last Reviewed
2014-Mar-01
Date
2000-Aug-16
Topics
Health human resources
Health information and e-health
Resolution
GC00-12
That General Council endorse Canadian Medical Association's offering of professional development to physicians as part of the Canadian Medical Association's e-strategy.
Less detail

National health care database

https://policybase.cma.ca/en/permalink/policy714
Date
1985-Aug-25
Topics
Health information and e-health
Resolution
GC85-45
The Canadian Medical Association recommends the development of a sound national health care database, accessible to health care professionals' associations and legitimate researchers.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1985-Aug-25
Topics
Health information and e-health
Resolution
GC85-45
The Canadian Medical Association recommends the development of a sound national health care database, accessible to health care professionals' associations and legitimate researchers.
Less detail

Non-medicinal ingredients in drug products

https://policybase.cma.ca/en/permalink/policy802
Date
1985-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC85-28
The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.
Policy Type
Policy resolution
Last Reviewed
2017-Mar-04
Date
1985-Aug-25
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC85-28
The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.
Less detail

6 records – page 1 of 1.